Harvard Bioscience, Inc.HBIONASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Year-over-year operating income growth rate
Latest
-427.93%
↓ 543% below average
Average (9y)
96.56%
Historical baseline
Range
High:1074.26%
Low:-435.58%
CAGR
+14.6%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | -427.93% |
| 2023 | 127.32% |
| 2022 | -435.58% |
| 2021 | 834.84% |
| 2020 | -41.38% |
| 2019 | -61.69% |
| 2018 | 1074.26% |
| 2017 | 96.63% |
| 2016 | -74.96% |
| 2015 | -125.88% |